Veloxis Pharmaceuticals A/S announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was USD 14.261 million compared to USD 7.265 million a year ago. Operating income was USD 508,000 compared to of USD 3.368 million a year ago. Net income was USD 111,000 compared to net loss of USD 4.030 million a year ago.